Skip to Main Content

Author Details

Radek Fedr
Institute of Biophysics of the Czech Academy of Sciences
2013
39
12
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36550781Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness.Mol Oncol2023
36966193Variability of fluorescence intensity distribution measured by flow cytometry is influenced by cell size and cell cycle progression.Sci Rep2023
34994868Transcription factor c-Myb: novel prognostic factor in osteosarcoma.Clin Exp Metastasis2022
35750257Toll-Like Receptor 3 Overexpression Induces Invasion of Prostate Cancer Cells, whereas Its Activation Triggers Apoptosis.Am J Pathol2022
36087262High-Throughput, Parallel Flow Cytometry Screening of Hundreds of Cell Surface Antigens Using Fluorescent Barcoding.Methods Mol Biol2022
36077780Inhibition of Aryl Hydrocarbon Receptor (AhR) Expression Disrupts Cell Proliferation and Alters Energy Metabolism and Fatty Acid Synthesis in Colon Cancer Cells.Cancers (Basel)2022
35057061Incorporation of Low Concentrations of Gold Nanoparticles: Complex Effects on Radiation Response and Fate of Cancer Cells.Pharmaceutics2022
33297115A prolonged exposure of human lung carcinoma epithelial cells to benzo[a]pyrene induces p21-dependent epithelial-to-mesenchymal transition (EMT)-like phenotype.Chemosphere2021
34627992Polychlorinated environmental toxicants affect sphingolipid metabolism during neurogenesis in vitro.Toxicology2021
32404145Interleukin 4 inducible 1 gene (IL4I1) is induced in chicken phagocytes by Salmonella Enteritidis infection.Vet Res2020
33076532Nonhistone Proteins HMGB1 and HMGB2 Differentially Modulate the Response of Human Embryonic Stem Cells and the Progenitor Cells to the Anticancer Drug Etoposide.Biomolecules2020
32579780The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe.Mol Oncol2020
328507823D Cell Culture Models Demonstrate a Role for FGF and WNT Signaling in Regulation of Lung Epithelial Cell Fate and Morphogenesis.Front Cell Dev Biol2020
32647280TGF-β regulates Sca-1 expression and plasticity of pre-neoplastic mammary epithelial stem cells.Sci Rep2020
32590255Slug-expressing mouse prostate epithelial cells have increased stem cell potential.Stem Cell Res2020
32146299Natural pseurotins and analogs thereof inhibit activation of B-cells and differentiation into the plasma cells.Phytomedicine2020
32408543Ring-Substituted 1-Hydroxynaphthalene-2-Carboxanilides Inhibit Proliferation and Trigger Mitochondria-Mediated Apoptosis.Int J Mol Sci2020
30776675Generation of human iPSCs from fetal prostate fibroblasts HPrF.Stem Cell Res2019
34907719The frequency and consequences of multipolar mitoses in undifferentiated embryonic stem cells.J Appl Biomed2019
30952903High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells.Sci Rep2019
29220555Multiparameter cytometric analysis of complex cellular response.Cytometry A2018
29808688Flow Cytometric Analysis of Nucleoside Transporters Activity in Chemoresistant Prostate Cancer Model.Klin Onkol2018
30096372Irradiation by γ-rays reduces the level of H3S10 phosphorylation and weakens the G2 phase-dependent interaction between H3S10 phosphorylation and γH2AX.Biochimie2018
30010814Trop-2 plasticity is controlled by epithelial-to-mesenchymal transition.Carcinogenesis2018
29923310Depletion of A-type lamins and Lap2α reduces 53BP1 accumulation at UV-induced DNA lesions and Lap2α protein is responsible for compactness of irradiated chromatin.J Cell Biochem2018
30481741Generation of human iPSCs from human prostate cancer-associated fibroblasts IBPi002-A.Stem Cell Res2018
29750874Hematological findings in non-treated and gamma-irradiated mice deficient for MIC-1/GDF15.Physiol Res2018
29665654Hypericin affects cancer side populations via competitive inhibition of BCRP.Biomed Pharmacother2018
29462126Plasticity and intratumoural heterogeneity of cell surface antigen expression in breast cancer.Br J Cancer2018
28619751Synthesis and Profiling of a Novel Potent Selective Inhibitor of CHK1 Kinase Possessing Unusual N-trifluoromethylpyrazole Pharmacophore Resistant to Metabolic N-dealkylation.Mol Cancer Ther2017
29228002Comparative cell cycle transcriptomics reveals synchronization of developmental transcription factor networks in cancer cells.PLoS One2017
29025359BRCA1 or CDK12 loss sensitizes cells to CHK1 inhibitors.Tumour Biol2017
28623956Differential protein expression in chicken macrophages and heterophils in vivo following infection with Salmonella Enteritidis.Vet Res2017
28621911Different roles of CD4, CD8 and γδ T-lymphocytes in naive and vaccinated chickens during Salmonella Enteritidis infection.Proteomics2017
25737734Flavonoid 4'-O-Methylkuwanon E from Morus alba Induces the Differentiation of THP-1 Human Leukemia Cells.Evid Based Complement Alternat Med2015
26691337Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway.Microb Cell Fact2015
24884804The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells.Mol Cancer2014
25369338Properties of neural crest-like cells differentiated from human embryonic stem cells.Folia Biol (Praha)2014
23450810Automatic cell cloning assay for determining the clonogenic capacity of cancer and cancer stem-like cells.Cytometry A2013
  • 1 - 39 of 39

Recommended Authors

Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 0
Yale School of Public Health
Career Start Year 2012
Number of shared co-authors 0
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Career Start Year 2012
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Roswell Park Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
National Taiwan University College of Medicine
Career Start Year 2008
Number of shared co-authors 0
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 0
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 0
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
University of California los angeles
Career Start Year 2003
Number of shared co-authors 0
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 0
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Medical University of Graz
Career Start Year 2000
Number of shared co-authors 0
Foundation for the Finnish Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
Kaohsiung Medical University
Career Start Year 1998
Number of shared co-authors 0
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
College of Medicine, The Catholic University of Korea
Career Start Year 1996
Number of shared co-authors 0
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 0
Oncode Institute
Career Start Year 1993
Number of shared co-authors 1
University of Toronto
Career Start Year 1991
Number of shared co-authors 0
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University
Career Start Year 1987
Number of shared co-authors 0
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 0

Collaborators

Institute of Biophysics of the Czech Academy of Sciences
Co-authored papers 28
University of Vermont
Co-authored papers 2
Karolinska Institutet
Co-authored papers 1
Karolinska Institutet
Co-authored papers 1
Masaryk University
Co-authored papers 1
Masaryk University
Co-authored papers 1
Uppsala University
Co-authored papers 1
University of Southern California
Co-authored papers 1
Stockholm University
Co-authored papers 1
Karolinska Institutet
Co-authored papers 1
Karolinska Institutet
Co-authored papers 1
Karolinska Institute
Co-authored papers 1
Stanford University
Co-authored papers 1
KTH - Royal Institute of Technology
Co-authored papers 1
University of SS. Cyril and Methodius
Co-authored papers 1